| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM199209173271204 |
| P698 | PubMed publication ID | 1508244 |
| P2093 | author name string | M. Leppert | |
| M. Keating | |||
| G. M. Vincent | |||
| K. W. Timothy | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 846-852 | |
| P577 | publication date | 1992-09-01 | |
| 1992-09-17 | |||
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome | |
| P478 | volume | 327 |
| Q53432231 | A New Formula for Estimating the True QT Interval in Left Bundle Branch Block. |
| Q24316980 | A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome |
| Q24297875 | A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene |
| Q47692150 | A novel mutation in KVLQT1 is the molecular basis of inherited long QT syndrome in a near-drowning patient's family |
| Q41382464 | A practical approach to torsade de pointes |
| Q57807345 | A single strand conformation polymorphism/heteroduplex (SSCP/HD) method for detection of mutations in 15 exons of the KVLQT1 gene, associated with long QT syndrome |
| Q34734831 | AKAP9 is a genetic modifier of congenital long-QT syndrome type 1 |
| Q70736188 | Abnormalities of the corrected QT interval in familial dysautonomia: an indicator of autonomic dysfunction |
| Q46761975 | Acquired QT prolongation associated with esophagitis and acute weight loss: how to evaluate a prolonged QT interval |
| Q35691352 | Age-and sex-dependent mRNA expression of KCNQ1 and HERG in patients with long QT syndrome type 1 and 2. |
| Q50980218 | Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. |
| Q52200912 | Allgrove syndrome: documenting cholinergic dysfunction by autonomic tests. |
| Q33173990 | Analysis of HLA and disease susceptibility: chromosome 6 genes and sex influence long-QT phenotype |
| Q35049104 | Another cause of sudden infant death syndrome: report of a clinical case of congenital long QT syndrome |
| Q33145007 | Antiarrhythmic drug initiation in patients with atrial fibrillation |
| Q42850768 | Arrhythmia risk in long QT syndrome: beyond the disease-causative mutation |
| Q33145152 | Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts |
| Q36592201 | Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records |
| Q33145181 | Asthma and the risk of cardiac events in the Long QT syndrome. Long QT Syndrome Investigative Group |
| Q33175954 | Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). |
| Q47344917 | Automated QT analysis on Holter monitors in pediatric patients can differentiate long QT syndrome from controls. |
| Q35074324 | Benefits and risks of newer treatments for chemotherapy-induced and postoperative nausea and vomiting |
| Q71874226 | Blunt Impact to the Chest Leading to Sudden Death from Cardiac Arrest during Sports Activities |
| Q35831609 | Brugada and long QT-3 syndromes: two phenotypes of the sodium channel disease. |
| Q72198090 | Calculation of QTc duration and variability in the presence of sinus arrhythmia |
| Q36596713 | Can pharmacogenetics help rescue drugs withdrawn from the market? |
| Q34667992 | Challenges of diagnosis of long-QT syndrome in children. |
| Q33147293 | Clinical and therapeutic aspects of congenital and acquired long QT syndrome |
| Q33151688 | Clinical characteristics of 5 Chinese LQTS families and phenotype-genotype correlation |
| Q77579194 | Clinical characteristics of sudden death victims in heritable (chromosome 1p1-1q1) conduction and myocardial disease |
| Q50485508 | Cochlear implantation in Jervell and Lange-Nielsen syndrome |
| Q48274112 | Commentary on: Gibbons J, Mojica A, Peele M. Human electrical muscular incapacitation and effects on QTc interval. J Forensic Sci https://doi.org/10.1111/1556-4029.13490. Epub 2017 April 17. |
| Q33145050 | Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. |
| Q51975643 | Comparison of the four formulas of adjusting QT interval for the heart rate in the middle-aged healthy Turkish men. |
| Q33165312 | Congenital and drug-induced long-QT syndrome: an update |
| Q58010712 | Congenital long QT syndrome |
| Q33146443 | Congenital long QT syndrome |
| Q34241023 | Congenital long QT syndromes and Brugada syndrome: the arrhythmogenic ion channel disorders |
| Q33153847 | Congenital long QT syndromes: clinical features, molecular genetics and genetic testing |
| Q33145001 | Congenital long-QT syndrome: a case report illustrating diagnostic pitfalls |
| Q34660661 | Congenital long-QT syndromes: a clinical and genetic update from infancy through adulthood |
| Q38323637 | Controversies in arrhythmias and arrhythmic syndromes of active children and young adults |
| Q34166813 | Corrected QT Interval in Children With Brain Death |
| Q89671400 | Critical assessment of secondary findings in genes linked to primary arrhythmia syndromes |
| Q37317751 | Deleting the accessory subunit KChIP2 results in loss of I(to,f) and increased I(K,slow) that maintains normal action potential configuration. |
| Q27030767 | Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes |
| Q79095263 | Diagnostic Performance of Various QTc Interval Formulas in a Large Family with Long QT Syndrome Type 3: Bazett's Formula Not So Bad After All … |
| Q46336749 | Differentiation between LQT1 and LQT2 patients and unaffected subjects using 24-hour electrocardiographic recordings |
| Q35874546 | Distinct gene-specific mechanisms of arrhythmia revealed by cardiac gene transfer of two long QT disease genes, HERG and KCNE1. |
| Q33661027 | Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives |
| Q34984908 | Drug-induced torsades de pointes and implications for drug development. |
| Q71807499 | ECG T-Wave Patterns in Genetically Distinct Forms of the Hereditary Long QT Syndrome |
| Q33150556 | Effect of Phenylephrine Provocation on Dispersion of Repolarization in Congenital Long QT Syndrome |
| Q50888556 | Effect of physical training on QTc interval in elderly people. |
| Q34258846 | Electrocardiogram screening for disorders that cause sudden cardiac death in asymptomatic children: a meta-analysis |
| Q34626051 | Endophenotypes in bipolar disorder |
| Q37578478 | Endophenotypes of obsessive-compulsive disorder: rationale, evidence and future potential. |
| Q44323034 | Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. |
| Q64239887 | Error-related brain activity as a transdiagnostic endophenotype for obsessive-compulsive disorder, anxiety and substance use disorder |
| Q33146594 | Evaluation and treatment of pediatric patients with congenital or acquired long QT interval syndromes |
| Q77107620 | Evaluation of QT interval duration and dispersion and proposed clinical criteria in diagnosis of long QT syndrome in patients with a genetically uniform type of LQT1 |
| Q46119652 | Evidence for a heritable unidimensional symptom factor underlying obsessionality |
| Q33677532 | Evidence of a long QT founder gene with varying phenotypic expression in South African families |
| Q37078819 | Family history: an essential tool for cardiovascular genetic medicine |
| Q73084017 | Fetus with long QT syndrome manifested by tachyarrhythmia: a case report |
| Q47398470 | Four potassium channel mutations account for 73% of the genetic spectrum underlying long-QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland |
| Q34811193 | Genetic disorders of neuromuscular ion channels |
| Q38118161 | Genetic etiology and evaluation of sudden cardiac death |
| Q33173947 | Genetic linkage analyses of Romano-Ward syndrome (RWS) in 13 Japanese families. |
| Q42589382 | Genetic screening in acquired long QT syndrome? CAUTION: proceed carefully |
| Q36994901 | Genetic testing in heritable cardiac arrhythmia syndromes: differentiating pathogenic mutations from background genetic noise |
| Q37587475 | Genetic testing in the management of inherited arrhythmia syndromes |
| Q40493112 | Genetics and Molecular Biology of the Inherited Long QT Syndrome |
| Q41746723 | Genetics, molecular mechanisms and management of long QT syndrome |
| Q35638684 | Genotype- and mutation site-specific QT adaptation during exercise, recovery, and postural changes in children with long-QT syndrome |
| Q33161338 | Genotype-phenotype analysis of three Chinese families with Jervell and Lange-Nielsen syndrome |
| Q36811302 | Genotype-specific QT correction for heart rate and the risk of life-threatening cardiac events in adolescents with congenital long-QT syndrome |
| Q35696315 | Genotype-specific clinical manifestation in long QT syndrome |
| Q38004348 | HERG potassium channel regulation by the N-terminal eag domain |
| Q33401777 | High prevalence of four long QT syndrome founder mutations in the Finnish population |
| Q38094947 | Identification and characterization of a novel genetic mutation with prolonged QT syndrome in an unexplained postoperative death. |
| Q37396467 | Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome |
| Q33156860 | Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy |
| Q45967391 | Identifying drug-induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: a study of sotalol effects on T-wave morphology. |
| Q35335917 | Importance of cardiological evaluation for first seizures. |
| Q43758763 | Inclusion body myositis associated with hepatitis C virus infection |
| Q77492129 | Is exercise testing useful in identifying congenital long QT syndrome? |
| Q97527184 | Is there a relationship between epicardial fat tissue thickness and Tp-Te/QT ratio in healthy individuals? |
| Q100751430 | Jervell and Lange-Nielsen syndrome with novel KCNQ1 and additional gene mutations |
| Q33145164 | Jervell and Lange-Nielsen syndrome: neurologic and cardiologic evaluation |
| Q33148846 | KCNQ1 mutations in patients with a family history of lethal cardiac arrhythmias and sudden death |
| Q33886242 | KCNQ1 p.L353L affects splicing and modifies the phenotype in a founder population with long QT syndrome type 1. |
| Q35232662 | LQT5 masquerading as LQT2: a dominant negative effect of KCNE1-D85N rare polymorphism on KCNH2 current. |
| Q48026950 | LQTS in Northern BC: homozygosity for KCNQ1 V205M presents with a more severe cardiac phenotype but with minimal impact on auditory function |
| Q30862747 | Laser surgery in a patient with Romano-Ward (long QT) syndrome and an automatic implantable cardioverter defibrillator |
| Q71739600 | Linkage of the long QT syndrome to the short arm of chromosome 11: use of five highly polymorphic markers towards more detailed localization of the mutant gene |
| Q42950814 | Localization of Romano-Ward long QT syndrome gene, LQT1, to the interval between tyrosine hydroxylase (TH) and D11S1349. |
| Q33174117 | Locus heterogeneity of autosomal dominant long QT syndrome |
| Q73885519 | Long QT syndrome |
| Q35110930 | Long QT syndrome caused by noncardiac drugs |
| Q39676342 | Long QT syndrome: A therapeutic challenge |
| Q38113488 | Long QT syndrome: beyond the causal mutation |
| Q33145098 | Long QT syndromes and torsade de pointes |
| Q34569221 | Long QTc interval and torsade de pointes caused by fluconazole |
| Q33772270 | Macrolide antibiotics and the risk of cardiac arrhythmias |
| Q48240224 | Manifestation of Long QT syndrome with normal QTc interval under anesthesia: a case report |
| Q24672105 | Mapping of a gene for long QT syndrome to chromosome 4q25-27 |
| Q36040772 | Mechanistic basis of adverse drug reactions: the perils of inappropriate dose schedules |
| Q34336568 | MicroRNAs in cardiac arrhythmia: DNA sequence variation of MiR-1 and MiR-133A in long QT syndrome |
| Q33158823 | Microvolt T-wave alternans during Holter monitoring in children and adolescents. |
| Q37340699 | Missing heritability of complex diseases: Enlightenment by genetic variants from intermediate phenotypes |
| Q33149140 | Modulating effects of age and gender on the clinical course of long QT syndrome by genotype |
| Q33174777 | Molecular analysis at the Harvey Ras-1 gene in patients with long QT syndrome |
| Q34175373 | Molecular and cellular mechanisms of cardiac arrhythmias |
| Q40836393 | Molecular diagnostics for cardiovascular disease |
| Q28292102 | Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers |
| Q33174174 | Molecular genetic aspects of the Romano-Ward long QT syndrome |
| Q33146080 | Morphological algebraic models of the TU-wave patterns/in idiopathic long QT syndrome |
| Q44583231 | Multiscale cardiac modelling reveals the origins of notched T waves in long QT syndrome type 2. |
| Q51523616 | Mutation analysis for the detection of long QT-syndrome (LQTS) associated SNPs. |
| Q33163894 | Mutation analysis of KCNQ1, KCNH2, SCN5A, KCNE1 and KCNE2 genes in Chinese patients with long QT syndrome |
| Q30484477 | Neurophyisological and neurocognitive endophenotypes for schizophrenia genetics research |
| Q33165952 | Obstructive Sleep Apnea in Patients with Congenital Long QT Syndrome: Implications for Increased Risk of Sudden Cardiac Death |
| Q72500860 | On the pulse of genetic cardiology |
| Q33146419 | Out-of-hospital cardiac arrest in a child without overt cardiac disease: emergency department management |
| Q33942230 | PQ segment depression in patients with short QT syndrome: a novel marker for diagnosing short QT syndrome? |
| Q35645901 | Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing |
| Q35038052 | Pharmacogenetics in drug regulation: promise, potential and pitfalls |
| Q33175748 | Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease: classification, differential diagnosis, and implications for therapy |
| Q35786498 | Pre-participation Cardiovascular Screening of Elderly Wrestlers. |
| Q47563306 | Prenatal diagnosis and in utero treatment of torsades de pointes associated with congenital long QT syndrome |
| Q33175112 | Prenatal findings in patients with prolonged QT interval in the neonatal period |
| Q37442080 | Prevalence of the congenital long-QT syndrome. |
| Q33148630 | Prolonged QT syndrome in children: an uncommon but potentially fatal entity |
| Q33371126 | Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations |
| Q34658194 | Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT responses in patients with long QT syndrome: a bedside test for diagnosing long QT syndrome. |
| Q54144793 | QT interval change with age in an overtly healthy older population. |
| Q51571943 | QTc interval (cardiac repolarization): lengthening after meals. |
| Q33148196 | QTc prolongation in apheresis platelet donors |
| Q33157779 | QTc: how long is too long? |
| Q45208218 | Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. |
| Q34186776 | Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes |
| Q33156201 | Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome |
| Q35904744 | Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals |
| Q38197159 | Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management |
| Q33156334 | Risk of death in the long QT syndrome when a sibling has died |
| Q33160341 | Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation |
| Q41580261 | Risk profiles and cardiovascular preparticipation screening of competitive athletes |
| Q24317024 | SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome |
| Q37272341 | Segmental duplications mediate novel, clinically relevant chromosome rearrangements |
| Q37776345 | Short QT interval in clinical practice |
| Q43806425 | Significance of screening electrocardiogram before the initiation of amitriptyline therapy in children with functional abdominal pain |
| Q54095734 | Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. |
| Q73047600 | Sodium channel abnormalities are infrequent in patients with long QT syndrome: identification of two novel SCN5A mutations |
| Q72897072 | Stress-induced polymorphous ventricular tachyarrhythmias in two brothers: unusual pattern of inheritance in the long QT syndrome |
| Q37551182 | Sudden cardiac arrest in the young due to inherited arrhythmias: the importance of family care |
| Q42158153 | Sudden cardiac death in children and adolescents (excluding Sudden Infant Death Syndrome). |
| Q38250400 | Sudden cardiac death in the young: the bogeyman |
| Q36232414 | Sudden cardiac death without structural heart disease: update on the long QT and Brugada syndromes |
| Q33149326 | Syncope in children and adolescents and the congenital long QT syndrome |
| Q47117871 | Ten-year experience in atenolol use and exercise evaluation in children with genetically proven long QT syndrome |
| Q37770572 | The genetic and clinical features of cardiac channelopathies. |
| Q28262724 | The genetic basis of long QT and short QT syndromes: a mutation update |
| Q58011071 | The long QT syndrome |
| Q80210284 | The long QT syndrome |
| Q41348224 | The long QT syndromes |
| Q33970623 | The long QT syndromes: genetic basis and clinical implications |
| Q26864392 | The molecular autopsy: should the evaluation continue after the funeral? |
| Q77475359 | The molecular basis of long QT syndrome and prospects for therapy |
| Q40846746 | The molecular genetics of arrhythmias and sudden death |
| Q36338332 | The phenomenon of "QT stunning": the abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndrome |
| Q37088498 | The primary arrhythmia syndromes: same mutation, different manifestations. Are we starting to understand why? |
| Q33820481 | The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome |
| Q41018413 | The serum- and glucocorticoid-inducible kinases SGK1 and SGK3 regulate hERG channel expression via ubiquitin ligase Nedd4-2 and GTPase Rab11. |
| Q37864963 | The short QT syndrome |
| Q41047262 | Triggers for sudden cardiac death in the athlete. |
| Q58011214 | Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity |
| Q33157458 | Value of history-taking in syncope patients: in whom to suspect long QT syndrome? |
| Q33147371 | Variable expression of long QT syndrome among gene carriers from families with five different HERG mutations |
| Q35830168 | Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner |
| Q33147996 | Ventricular tachycardia in structurally normal hearts |
| Q80025219 | [Clinical outcome of beta blocker therapy in a patient with long QT syndrome with a critical mutation in the pore of potassium channel] |
| Q74603942 | [Genetic bases of arrhythmias] |
Search more.